← Back to catalogue

Eclipse Treatment Planning System (v18.0)

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K230557Ref Eclipse Treatment Planning System 18.1Ref Eclipse Treatment Planning System 16.1

by Varian Medical Systems, Inc.

Identity

Trade Name
Eclipse Treatment Planning System EUDAMEDFDA UDI
Eclipse Treatment Planning System for External Beam Radiation Therapy FDA UDI
Generic Name
Radiation therapy software FDA UDI
Device Name
Eclipse Treatment Planning System EUDAMED
Model / Reference
Eclipse Treatment Planning System 18.1 EUDAMED
Eclipse Treatment Planning System 16.1 EUDAMED
18.1 FDA UDI
16.1 FDA UDI

Identifiers

Primary DI / UDI-DI
00855141006349 EUDAMEDFDA UDI
00855141006080 EUDAMEDFDA UDI
Basic UDI-DI
089947500200107PN EUDAMED
510(k) Number
K230557 FDA 510(k)
K242378 FDA UDI
K201607 FDA UDI
FDA Product Code
MUJ FDA 510(k)FDA UDI
EMDN Code
Z11010401 RADIOTHERAPY TREATMENT PLANNING SYSTEMS EUDAMED
Z11010482 RADIOTHERAPY TREATMENT PLANNING INSTRUMENTS - SOFTWARE ACCESSORIES EUDAMED
GMDN Term
Radiation therapy software FDA UDI

Classification

Device Class
Class IIb EUDAMED
Class II FDA 510(k)FDA UDI
Legislation / Framework
21 CFR Part 892.5050 FDA 510(k)
Regulation Number
892.5050 FDA 510(k)FDA UDI
Special Device Type
Software EUDAMED
Market of Registration
Netherlands EUDAMED
Advisory Committee
Radiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

The Eclipse Treatment Planning System (v18.0) is a computer-based software system classified as a Radiation Therapy Treatment Planning System. It is designed to assist radiation oncologists and physicists in creating precise, individualized radiation treatment plans for cancer patients by simulating dose distributions and optimizing therapy parameters.

This system is supplied as a software license for installation on compatible hardware within radiation oncology departments. It operates in non-sterile environments and is intended for single-user, multi-session use in clinical settings. The system has received FDA 510(k) clearance and is compliant with the EU Medical Device Regulation (MDR). No specific MRI safety classification or sterility requirements are noted in the provided data.

Frequently asked questions

What is the Eclipse Treatment Planning System (v18.0) used for in a clinical setting?

The Eclipse Treatment Planning System (v18.0) is designed to assist radiation oncologists and physicists in creating precise, individualized radiation treatment plans for cancer patients. It simulates dose distributions and optimizes therapy parameters to help ensure accurate and effective radiation therapy delivery.

How is the Eclipse Treatment Planning System supplied and where is it used?

The Eclipse Treatment Planning System is supplied as a software license for installation on compatible hardware within radiation oncology departments. It operates in non-sterile environments and is intended for single-user, multi-session use in clinical settings, meaning it is not meant for sterile procedures or shared use outside of authorized installations.

Is the Eclipse Treatment Planning System reusable or single-use, and what are its regulatory approvals?

The Eclipse Treatment Planning System is intended for single-user, multi-session use, meaning it is not a single-use device but rather a reusable software solution within its designated clinical environment. It has received FDA 510(k) clearance and is compliant with the EU Medical Device Regulation (MDR), ensuring it meets regulatory standards for use in both U.S. and EU markets.

What type of hardware compatibility does the Eclipse Treatment Planning System require for installation?

The Eclipse Treatment Planning System requires installation on compatible hardware within radiation oncology departments, though the specific hardware requirements are not detailed in the provided data. It is a software-based system and does not include physical hardware components, so the clinical environment must meet the manufacturer’s technical specifications for proper operation.

How does the Eclipse Treatment Planning System relate to MRI safety, and what are its regulatory routes?

The Eclipse Treatment Planning System is not classified under MRI safety protocols, as it operates in non-sterile, non-imaging environments for radiation therapy planning. Its regulatory route includes FDA 510(k) clearance and compliance with the EU Medical Device Regulation (MDR), confirming its suitability for use in radiation oncology settings under these frameworks.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Eclipse | Siemens Healthineers | Cancer Care - Varian, Treatment planning software - Eclipse™ - Varian Oncology - medical ..., Eclipse Treatment Planning System (v18.0) (K230557) — FDA 510 (k ...

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (5)

  • FDA 510(k) K230557 24 fields · synced Oct 6, 2026
  • FDA UDI 3e73f954-917f-4db2-8c92-70be8a22aa44 33 fields · synced May 29, 2026
  • FDA UDI 84022bd5-aff8-49a2-b338-b24dae0d6151 33 fields · synced May 29, 2026
  • EUDAMED d2d29907-c637-4ed5-8177-d6c468ac735a 61 fields · synced Jul 21, 2026
  • EUDAMED 1e93b6ca-2702-4f33-bfeb-ba038b4b928c 61 fields · synced Jul 24, 2026